Khiron Life Sciences Corp. KHRNF

KHRNF Company Overview

Khiron Life Sciences Corp. is a medical cannabis and integrated healthcare company focused primarily on the production, distribution, and commercialization of medical cannabis products and related health services. The company operates in the regulated medical cannabis industry, with activities spanning pharmaceutical-grade cannabis cultivation, branded medical products, patient access programs, and healthcare clinic services. Khiron has historically concentrated on markets in Latin America and Europe, particularly jurisdictions with developing or expanding medical cannabis frameworks.

The company’s primary revenue drivers have included prescription medical cannabis products, clinic-based patient services, and distribution partnerships in regulated international markets. Khiron developed a vertically integrated strategy combining cultivation, medical education, physician networks, and patient access infrastructure. A key differentiator has been its emphasis on physician-led healthcare ecosystems through its Zerenia clinic network and its focus on emerging medical cannabis markets where regulatory barriers limit competition. Founded in 2017 and headquartered in Toronto, Canada, the company expanded through acquisitions, clinic development, and international licensing initiatives as medical cannabis regulations evolved globally.